Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Operative mortality after coronary artery bypass graft surgery

Sary Aranki, MD
Donald Cutlip, MD
Julian M Aroesty, MD
Section Editors
Gabriel S Aldea, MD
Edward Verrier, MD
Bernard J Gersh, MB, ChB, DPhil, FRCP, MACC
Deputy Editor
Gordon M Saperia, MD, FACC


The treatment of coronary heart disease has evolved significantly due in part to improvements in both medical therapy and surgical and percutaneous revascularization techniques. The majority of patients with chronic stable angina are treated with medical therapy, but there are a variety of indications for coronary artery bypass graft surgery (CABG) or percutaneous coronary intervention. (See "Stable ischemic heart disease: Indications for revascularization".)

The perioperative and in-hospital mortality rate after CABG will be reviewed here. Cardiac and noncardiac complications of CABG and the long-term outcome after CABG are discussed separately. (See "Early cardiac complications of coronary artery bypass graft surgery" and "Early noncardiac complications of coronary artery bypass graft surgery" and "Coronary artery bypass graft surgery: Causes and rates of graft failure".)


The 2011 American College of Cardiology/American Heart Association guideline for CABG issued general recommendations for preventive measures to minimize the risk of both morbidity and mortality after CABG [1]:

Aspirin to improve morbidity and mortality

Beta blockers to prevent perioperative atrial fibrillation; amiodarone and sotalol are alternatives

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Nov 2017. | This topic last updated: Nov 14, 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011; 124:e652.
  2. Hannan EL, Racz MJ, Walford G, et al. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med 2005; 352:2174.
  3. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002; 346:1128.
  4. Peterson ED, Coombs LP, DeLong ER, et al. Procedural volume as a marker of quality for CABG surgery. JAMA 2004; 291:195.
  5. Nallamothu BK, Saint S, Hofer TP, et al. Impact of patient risk on the hospital volume-outcome relationship in coronary artery bypass grafting. Arch Intern Med 2005; 165:333.
  6. Cram P, Rosenthal GE, Vaughan-Sarrazin MS. Cardiac revascularization in specialty and general hospitals. N Engl J Med 2005; 352:1454.
  7. Ribeiro AL, Gagliardi SP, Nogueira JL, et al. Mortality related to cardiac surgery in Brazil, 2000-2003. J Thorac Cardiovasc Surg 2006; 131:907.
  8. Edwards FH, Clark RE, Schwartz M. Coronary artery bypass grafting: the Society of Thoracic Surgeons National Database experience. Ann Thorac Surg 1994; 57:12.
  9. Hattler BG, Madia C, Johnson C, et al. Risk stratification using the Society of Thoracic Surgeons Program. Ann Thorac Surg 1994; 58:1348.
  10. www.sts.org www.sts.org (Accessed on August 20, 2014).
  11. Roques F, Nashef SA, Michel P, et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 1999; 15:816.
  12. Nashef SA, Roques F, Michel P, et al. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999; 16:9.
  13. Nashef SA, Roques F, Hammill BG, et al. Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery. Eur J Cardiothorac Surg 2002; 22:101.
  14. Nilsson J, Algotsson L, Höglund P, et al. Early mortality in coronary bypass surgery: the EuroSCORE versus The Society of Thoracic Surgeons risk algorithm. Ann Thorac Surg 2004; 77:1235.
  15. Nilsson J, Algotsson L, Höglund P, et al. Comparison of 19 pre-operative risk stratification models in open-heart surgery. Eur Heart J 2006; 27:867.
  16. Kolh P. Importance of risk stratification models in cardiac surgery. Eur Heart J 2006; 27:768.
  17. Ranucci M, Castelvecchio S, Menicanti L, et al. Risk of assessing mortality risk in elective cardiac operations: age, creatinine, ejection fraction, and the law of parsimony. Circulation 2009; 119:3053.
  18. Singh M, Rihal CS, Lennon RJ, et al. Bedside estimation of risk from percutaneous coronary intervention: the new Mayo Clinic risk scores. Mayo Clin Proc 2007; 82:701.
  19. Singh M, Gersh BJ, Li S, et al. Mayo Clinic Risk Score for percutaneous coronary intervention predicts in-hospital mortality in patients undergoing coronary artery bypass graft surgery. Circulation 2008; 117:356.
  20. Nallamothu BK, Saint S, Ramsey SD, et al. The role of hospital volume in coronary artery bypass grafting: is more always better? J Am Coll Cardiol 2001; 38:1923.
  21. Wu C, Hannan EL, Ryan TJ, et al. Is the impact of hospital and surgeon volumes on the in-hospital mortality rate for coronary artery bypass graft surgery limited to patients at high risk? Circulation 2004; 110:784.
  22. Fortescue EB, Kahn K, Bates DW. Development and validation of a clinical prediction rule for major adverse outcomes in coronary bypass grafting. Am J Cardiol 2001; 88:1251.
  23. Yau TM, Fedak PW, Weisel RD, et al. Predictors of operative risk for coronary bypass operations in patients with left ventricular dysfunction. J Thorac Cardiovasc Surg 1999; 118:1006.
  24. Daly LE, Lonergan M, Graham I. Predicting operative mortality after coronary artery bypass surgery in males. Q J Med 1993; 86:771.
  25. Ivanov J, Weisel RD, David TE, Naylor CD. Fifteen-year trends in risk severity and operative mortality in elderly patients undergoing coronary artery bypass graft surgery. Circulation 1998; 97:673.
  26. Baskett R, Buth K, Ghali W, et al. Outcomes in octogenarians undergoing coronary artery bypass grafting. CMAJ 2005; 172:1183.
  27. Karkouti K, Wijeysundera DN, Yau TM, et al. Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation 2009; 119:495.
  28. Zakeri R, Freemantle N, Barnett V, et al. Relation between mild renal dysfunction and outcomes after coronary artery bypass grafting. Circulation 2005; 112:I270.
  29. Cooper WA, O'Brien SM, Thourani VH, et al. Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database. Circulation 2006; 113:1063.
  30. Hillis GS, Croal BL, Buchan KG, et al. Renal function and outcome from coronary artery bypass grafting: impact on mortality after a 2.3-year follow-up. Circulation 2006; 113:1056.
  31. Chaitman BR, Alderman EL, Sheffield LT, et al. Use of survival analysis to determine the clinical significance of new Q waves after coronary bypass surgery. Circulation 1983; 67:302.
  32. Bassan MM, Oatfield R, Hoffman I, et al. New Q waves after aortocoronary bypass surgery. Unmasking of an old infarction. N Engl J Med 1974; 290:349.
  33. Loop FD, Lytle BW, Cosgrove DM, et al. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med 1986; 314:1.
  34. Cameron A, Davis KB, Green G, Schaff HV. Coronary bypass surgery with internal-thoracic-artery grafts--effects on survival over a 15-year period. N Engl J Med 1996; 334:216.
  35. Leavitt BJ, O'Connor GT, Olmstead EM, et al. Use of the internal mammary artery graft and in-hospital mortality and other adverse outcomes associated with coronary artery bypass surgery. Circulation 2001; 103:507.
  36. Lytle BW, Blackstone EH, Loop FD, et al. Two internal thoracic artery grafts are better than one. J Thorac Cardiovasc Surg 1999; 117:855.
  37. Ioannidis JP, Galanos O, Katritsis D, et al. Early mortality and morbidity of bilateral versus single internal thoracic artery revascularization: propensity and risk modeling. J Am Coll Cardiol 2001; 37:521.
  38. Endo M, Nishida H, Tomizawa Y, Kasanuki H. Benefit of bilateral over single internal mammary artery grafts for multiple coronary artery bypass grafting. Circulation 2001; 104:2164.
  39. O'Connor GT, Morton JR, Diehl MJ, et al. Differences between men and women in hospital mortality associated with coronary artery bypass graft surgery. The Northern New England Cardiovascular Disease Study Group. Circulation 1993; 88:2104.
  40. O'Connor NJ, Morton JR, Birkmeyer JD, et al. Effect of coronary artery diameter in patients undergoing coronary bypass surgery. Northern New England Cardiovascular Disease Study Group. Circulation 1996; 93:652.
  41. Vaccarino V, Abramson JL, Veledar E, Weintraub WS. Sex differences in hospital mortality after coronary artery bypass surgery: evidence for a higher mortality in younger women. Circulation 2002; 105:1176.
  42. Rodriguez F, Nguyen TC, Galanko JA, Morton J. Gastrointestinal complications after coronary artery bypass grafting: a national study of morbidity and mortality predictors. J Am Coll Surg 2007; 205:741.
  43. Echahidi N, Pibarot P, Després JP, et al. Metabolic syndrome increases operative mortality in patients undergoing coronary artery bypass grafting surgery. J Am Coll Cardiol 2007; 50:843.
  44. Kulier A, Levin J, Moser R, et al. Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery. Circulation 2007; 116:471.
  45. van Straten AH, Hamad MA, van Zundert AJ, et al. Preoperative hemoglobin level as a predictor of survival after coronary artery bypass grafting: a comparison with the matched general population. Circulation 2009; 120:118.
  46. Zindrou D, Taylor KM, Bagger JP. Preoperative haemoglobin concentration and mortality rate after coronary artery bypass surgery. Lancet 2002; 359:1747.
  47. Koch CG, Li L, Sessler DI, et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008; 358:1229.